Skip to main content
. 2018 Jul 30;7(9):e1468953. doi: 10.1080/2162402X.2018.1468953

Figure 3.

Figure 3.

Plasma levels of IFN-γ (A), TNF-α (B), TGF-β (C), IL-10 (D), CXCL12 (E) and sB7-H6 (F) measured in 13 subjects, at study entry (basal) and after 1 or 2 cycles of imatinib mesylate. Each subject is indicated by the same symbol in all graphs.